×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Realizing Value Through Responsible AI in Clinical Development
Session Chair(s)
Stephen Pyke, MSc
Chief Clinical Data and Digital Officer
Parexel, United Kingdom
Leveraging expertise from industry, this session will explore how responsible AI frameworks can maximize value in clinical research by ensuring ethical, transparent, and accountable AI use.
Learning Objective : Recognize a set of responsible principles for AI in drug development; Demonstrate the ability to drive innovation and strategic advantage in AI-driven clinical trials; Propose how organizations can lead with integrity and trust in their AI applications.
Speaker(s)
Patient perspectives on AI in clinical development
Alicia Staley, MBA, MS
Medidata, a Dassault Systèmes Company, United States
Chief Patient Officer
Regulatory perspectives on AI in clinical development
Representative Invited
FDA, United States
Industry perspectives on AI in clinical development
Raja Shankar, MS
IQVIA, United Kingdom
Vice President, Machine Learning
Have an account?